📰 Lantern Pharma News
Page 8 - Lantern Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lantern Pharma. Real-time updates on events, politics, business and more.
March 22, 2022
/PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and...
March 10, 2022
/PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and...
March 10, 2022
/PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and...
January 24, 2022
The region's wide-ranging healthcare industry represents about 15 percent of the local economy.
January 18, 2022
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...
January 18, 2022
They will use expanded mutational signature analyses to identify new biomarker-defined indications in multiple tumor types.
January 13, 2022
Lantern Pharma the US National Institutes of Health unit NCI's DTB have extensed oncology collaboration for clinical trials for LP-184 and LP-284.
January 12, 2022
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...
January 10, 2022
Get to know the finalists in the 2022 Innovation Awards, brought to you by D CEO and Dallas Innovates. Winners will be revealed Jan. 12.
January 4, 2022
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...